Cited by 1,360Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

The DOI matches its Crossref record; 179 of the 181 references it cites were found in a registry or an index.

Polycystic ovary syndrome

Norman, Robert J, Dewailly, Didier, Legro, Richard S, Hickey, Theresa E·2007·The Lancet

DOI 10.1016/s0140-6736(07)61345-2

Open this paper in CoChat — free account

Abstract

Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(07)61345-2

Cites

179 of 179 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Clinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citation
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121

Show all 181 references

Research works printed but not linked: 5

Azziz, 2006, Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess Society guideline, J Clin Endocrinol Metab, 91, 4237, 10.1210/jc.2006-0178 · DOI · Paper page
Legro, 1999, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women, J Clin Endocrinol Metab, 84, 165
Legro, 2006, Pregnancy in polycystic ovary syndrome (PPCOS) baseline characteristics: effect of race and ethnicity on the PCOS phenotype, J Soc Gynecol Investig, 13, 268a
van Vloten, 2002, The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea, Cutis, 69, 2
Hughes, 2000, Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome, Cochrane Database Syst Rev, 2

Sorted by citations

Items 401–500 of 1,000

Effects of letrozole and clomiphene citrate on Wnt signaling pathway in endometrium of polycystic ovarian syndrome and healthy women†
Mehdinejadiani, S., Amidi, F., Mehdizadeh, M., Barati, M., Pazhohan, A., Alyasin, A., Mehdinejadiani, K., & Sobhani, A. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy187 · Cited by 36
Elevated expression of IL-18 but not IL-1β gene is associated with NALP3 and AIM2 inflammasome in Polycystic Ovary Syndrome
Rostamtabar, M., Esmaeilzadeh, S., Karkhah, A., Amiri, M., Rahmani, A., Bakouei, F., & Nouri, H. R. (2020) · Gene · doi:10.1016/j.gene.2020.144352 · Cited by 36
Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
Chi, J., Lin, P., Tolstikov, V., Oyekunle, T. O., Chen, E. Y.-S., Bussberg, V., Greenwood, B. P., Sarangarajan, R., Narain, N. R., Kiebish, M. A., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3016 · Cited by 38
The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats
Rababa’h, A. M., Matani, B. R., & Ababneh, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118353 · Cited by 36
The influence of obesity on ICSI outcomes in women with polycystic ovary syndrome
Özgün, M. T., Uludağ, S. Z., Öner, G., Batukan, C., Aygen, E., & Sahin, Y. (2011) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2010.546906 · Cited by 36
Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: a meta-analysis
Ruan, Y., Ma, J., & Xie, X. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej11-0387 · Cited by 36
High Fat Diet and Polycystic Ovary Syndrome (PCOS) in Adolescence: An Overview of Nutritional Strategies
Calcaterra, V., Magenes, V. C., Massini, G., De Sanctis, L., Fabiano, V., & Zuccotti, G. (2024) · Nutrients · doi:10.3390/nu16070938 · Cited by 35
Anti-Müllerian hormone: biology and role in endocrinology and cancers
Gowkielewicz, M., Lipka, A., Zdanowski, W., Waśniewski, T., Majewska, M., & Carlberg, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1468364 · Cited by 38
SGTA: A New Player in the Molecular Co-Chaperone Game
Philp, L., Butler, M. S., Hickey, T. E., Butler, L. M., Tilley, W. D., & Day, T. K. (2013) · Hormones and Cancer · doi:10.1007/s12672-013-0151-0 · Cited by 35
Self-citation
GC-MS analysis of Cocus nucifera flower extract and its effects on heterogeneous symptoms of polycystic ovarian disease in female Wistar rats
Soumya, V., Muzib, Y. I., Venkatesh, P., & Hariprasath, K. (2014) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(14)60103-5 · Cited by 35
Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Wang, Y., Fu, X., Xu, J., Wang, Q., & Kuang, H. (2016) · Scientific Reports · doi:10.1038/srep28089 · Cited by 36
Cardiovascular autonomic dysfunction in women with polycystic ovary syndrome: a systematic review and meta-analysis
Gui, J., & Wang, R. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.03.018 · Cited by 35
A strategic review on the involvement of receptors, transcription factors and hormones in acne pathogenesis
Bharti, S., & Vadlamudi, H. C. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1805626 · Cited by 43
DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of Polycystic Ovary Syndrome (PCOS)
Zhong, X., Jin, F., Huang, C., Du, M., Gao, M., & Wei, X. (2021) · Technology and Health Care · doi:10.3233/thc-218002 · Cited by 35
A new evidence‐based guideline for assessment and management of polycystic ovary syndrome
Norman, R. J., & Teede, H. J. (2018) · Medical Journal of Australia · doi:10.5694/mja18.00635 · Cited by 35
Self-citation
Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome
Kalra, P., Bansal, B., Nag, P., Singh, J. K., Gupta, R. K., Kumar, S., Rathore, R. K. S., Bhatia, V., & Bhatia, E. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.037 · Cited by 37
Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study
Xue, X., Liu, S., Yang, Y.-K., Xiaoning, L., Xi, W., & Mao, H. Z. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s83259 · Cited by 38
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome
Karbek, B., Ozbek, M., Karakose, M., Topaloglu, O., Bozkurt, N., Cakır, E., Aslan, M., & Delibasi, T. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-31 · Cited by 35
Is polycystic ovary syndrome a 20th Century phenomenon?
Rodgers, R. J., Suturina, L., Lizneva, D., Davies, M. J., Hummitzsch, K., Irving-Rodgers, H. F., & Robertson, S. A. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.01.019 · Cited by 34
Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin
Feng, W., Jia, Y., Zhang, D., & Shi, H.-R. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1101441 · Cited by 34
Prenatal Exposures and Anti-Müllerian Hormone in Female Adolescents
Fraser, A., McNally, W., Sattar, N. A., Anderson, E. L., Lashen, H., Fleming, R., Lawlor, D. A., & Nelson, S. M. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt137 · Cited by 34
Advances in Bioanalytical Techniques to Measure Steroid Hormones in Serum
French, D. (2016) · Bioanalysis · doi:10.4155/bio-2015-0025 · Cited by 34
Endothelial maintenance in health and disease: Importance of sex differences
Mudrovcic, N., Arefin, S., Craenenbroeck, A. H. V., & Kublickiene, K. R. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.011 · Cited by 34
Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome
Moulana, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.01.048 · Cited by 33
Molecular mechanisms underlying altered neurobehavioural development of female offspring of mothers with polycystic ovary syndrome: FOS-mediated regulation of neurotrophins in placenta
Wang, F., Xie, N., Zhou, J., Dai, M., Zhang, Q., Hardiman, P., & Qu, F. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102993 · Cited by 34
Polycystic ovary syndrome and risk of stillbirth: a nationwide register‐based study
Valgeirsdottir, H., Kallak, T. K., Poromaa, I. S., Jonsson, M., Roos, N., Lindström, L., & Wikström, A. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16890 · Cited by 34
Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study
Hosseinpanah, F., Barzin, M., Keihani, S., Tehrani, F. R., & Azizi, F. (2014) · Clinical Endocrinology · doi:10.1111/cen.12406 · Cited by 34
Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women
Márquez, J. L., Pacheco, A., Valdés, P. R., & Salazar, L. A. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.07.028 · Cited by 34
Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females
Bruni, V., Peruzzi, E., Dei, M., Nannini, S., Seravalli, V., Sisti, G., & Fambrini, M. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.018 · Cited by 34
How common is polycystic ovary syndrome in recurrent miscarriage?
Cocksedge, K. A., Saravelos, S. H., Metwally, M., & Li, T. C. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.06.003 · Cited by 34
Differences in sexual desire between women with clinical versus biochemical signs of hyperandrogenism in polycystic ovarian syndrome
Rellini, A. H., Stratton, N., Tonani, S., Santamaria, V., Brambilla, E., & Nappi, R. E. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.10.013 · Cited by 34
Resting metabolic rate and exercise capacity in women with polycystic ovary syndrome
Çoşar, E., Köken, G., Şahin, F. K., Akgün, L., Üçok, K., Genç, A., & Yılmazer, M. (2008) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2007.10.011 · Cited by 34
Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation
Tal, R., Seifer, D. B., Grazi, R. V., & Malter, H. E. (2014) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-12-82 · Cited by 34
The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome
Qi, X., Pang, Y., & Qiao, J. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.01.029 · Cited by 34
Biomarkers of Endothelial Dysfunction in Women With Polycystic Ovary Syndrome
Dambala, K., Paschou, S. Α., Michopoulos, A., Siasos, G., Goulis, D. G., Vavilis, D., & Tarlatzis, B. C. (2019) · Angiology · doi:10.1177/0003319719840091 · Cited by 37
Therapeutic exploration of polyherbal formulation against letrozole induced PCOS rats: A mechanistic approach
Balasubramanian, A., Pachiappan, S., Mohan, S., Harikrishnan, A., Karuppasamy, I., & Ramalingam, K. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15488 · Cited by 33
Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
Leonhardt, H., Hellström, M., Gull, B., Lind, A., Nilsson, L., Janson, P., & Stener-Victorin, E. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.022 · Cited by 32
Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism
Li, Y., Ma, Y., Chen, X., Wang, W., Li, Y., Zhang, Q., & Yang, D. (2012) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-012-9839-2 · Cited by 33
Differential Expression of microRNAs in the Ovaries from Letrozole-Induced Rat Model of Polycystic Ovary Syndrome
Li, D., Li, C., Xu, Y., Xu, D., Li, H., Gao, L., Chen, S., Fu, L., Xu, X., Liu, Y., et al. (2016) · DNA and Cell Biology · doi:10.1089/dna.2015.3145 · Cited by 33
Changes of The Uterine Tissue in Rats with Polycystic Ovary Syndrome Induced by Estradiol Valerate.
Mirabolghasemi, G., & Kamyab, Z. (2017) · PubMed Central · doi:10.22074/ijfs.2016.4794 · Cited by 33
Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome
Li, N., Li, Y., Qian, C., Liu, Q., Cao, W., Ma, M., He, R., Chen, R., Geng, R., & Liu, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.624504 · Cited by 35
Early prenatal androgenization results in diminished ovarian reserve in adult female rhesus monkeys
Dumesic, D. A., Patankar, M. S., Barnett, D. K., Lesnick, T. G., Hutcherson, B. A., & Abbott, D. H. (2009) · Human Reproduction · doi:10.1093/humrep/dep324 · Cited by 33
Day-to-day co-variations of psychological and physical symptoms of the menstrual cycle: Insights to individual differences in steroid reactivity
Kiesner, J., & Pastore, M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.07.011 · Cited by 33
Screening for Cushing’s syndrome in obese women with and without polycystic ovary syndrome
Putignano, P., Bertolini, M., Losa, M., & Cavagnini, F. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345217 · Cited by 33
Circ_0043532 regulates miR-182/SGK3 axis to promote granulosa cell progression in polycystic ovary syndrome
Lishuang, X., Xiong, F., Bai, Y., Xiao, J., Zhang, Y., Chen, J., & Li, Q. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00839-5 · Cited by 33
Circulating bile acid profile characteristics in PCOS patients and the role of bile acids in predicting the pathogenesis of PCOS
Yu, J., Zhang, Y., Zhu, Y., Li, Y., Lin, S., Liu, W., & Tao, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1239276 · Cited by 32
Age‐stratified thresholds of anti‐Müllerian hormone improve prediction of polycystic ovary syndrome over a population‐based threshold
Quinn, M. M., Kao, C., Ahmad, A., Haisenleder, D. J., Santoro, N. F., Eisenberg, E., Legro, R. S., Cedars, M. I., Huddleston, H. G., & the NIH/NICHD Reproductive Medicine Network (2017) · Clinical Endocrinology · doi:10.1111/cen.13415 · Cited by 32
Self-citation
Impact of Metformin on IVF Outcomes in Overweight and Obese Women With Polycystic Ovary Syndrome: A Randomized Double-Blind Controlled Trial
Abdalmageed, O. S., Farghaly, T., Abdelaleem, A. A., Abdelmagied, A. M., Ali, M. K., & Abbas, A. M. (2018) · Reproductive Sciences · doi:10.1177/1933719118765985 · Cited by 33
The relationship between clinical and biochemical characteristics and quality of life in patients with polycystic ovary syndrome
Amiri, M., Yarandi, R. B., Nahidi, F., Tohidi, M., & Tehrani, F. R. (2018) · Clinical Endocrinology · doi:10.1111/cen.13858 · Cited by 32
Anxiety in transition: Neuroendocrine mechanisms supporting the development of anxiety pathology in adolescence and young adulthood
Spielberg, J. M., Schwarz, J. M., & Matyi, M. A. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100791 · Cited by 37
Hyperandrogenism, insulin resistance and acanthosis nigricans (HAIR-AN syndrome): an extreme subphenotype of polycystic ovary syndrome
O'Brien, B., Dahiya, R., & KIMBLE, R. M. N. (2020) · BMJ Case Reports · doi:10.1136/bcr-2019-231749 · Cited by 32
Novel role of CXCL14 in modulating STAR expression in luteinized granulosa cells: implication for progesterone synthesis in PCOS patients
Qi, J., Li, J., Wang, Y., Wang, W., Zhu, Q., He, Y., Lu, Y., Wu, H., Li, X., Zhu, Z., et al. (2020) · Translational research · doi:10.1016/j.trsl.2020.10.009 · Cited by 32
Elevated baseline LH/FSH ratio is associated with poor ovulatory response but better clinical pregnancy and live birth in Chinese women with PCOS after ovulation induction
Xia, Q., Xie, L., Wu, Q., Cong, J., Ma, H., Li, J., Cai, W.-Y., & Wu, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13024 · Cited by 32
Successive and cyclic oral contraceptive pill pretreatment improves IVF/ICSI outcomes of PCOS patients and ameliorates hyperandrogenism and antral follicle excess
Pan, J., Liu, Y., Ke, Z.-H., Zhou, C., Meng, Q., Ding, G., Xu, G., Sheng, J., & Huang, H. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2014.995621 · Cited by 32
Reduced Circulating Androgen Levels After Gastric Bypass Surgery in Severely Obese Women
Ernst, B., Wilms, B., Thurnheer, M., & Schultes, B. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0823-9 · Cited by 32
Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes
de Wilde, M. A., Goverde, A. J., Veltman-Verhulst, S. M., Eijkemans, M. J. C., Franx, A., Fauser, B. C. J. M., & Koster, M. P. H. (2015) · Human Reproduction · doi:10.1093/humrep/dev072 · Cited by 31
Polycystic Ovary Syndrome (PCOS) and Fertility
Barbosa, G., de Sá, L. B. P. C., Rocha, D. R. T. W., & Arbex, A. K. (2016) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2016.61008 · Cited by 32
Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile
Ersoy, G. Ş., Ensarı, T. A., Vatansever, D., Emirdar, V., & Çevik, Ö. D. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1223286 · Cited by 32
Silencing of LncRNA steroid receptor RNA activator attenuates polycystic ovary syndrome in mice
Li, Y., Zhao, W., Wang, H., Chen, C., Zhou, D., Li, S., Zhang, X., Zhao, H., Zhou, D., & Chen, B. (2018) · Biochimie · doi:10.1016/j.biochi.2018.10.021 · Cited by 32
Cardiovascular autonomic modulation differences between moderate-intensity continuous and high-intensity interval aerobic training in women with PCOS: A randomized trial
Philbois, S. V., Ribeiro, V. B., Tank, J., dos Reis, R. M., Gerlach, D. A., & de Souza, H. C. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1024844 · Cited by 34
PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA‐induced granulosa cell apoptosis in vitro
Ji, X., Yao, Y., Wang, L., Liu, S., & Dong, X. (2023) · Drug Development Research · doi:10.1002/ddr.22027 · Cited by 31
Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats
Zhai, H., Wu, H., Xu, H., Weng, P., Xia, F., Chen, Y., & Lu, Y. (2012) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-10-5 · Cited by 31
Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial
Weiss, N. S., Nahuis, M. J., Bordewijk, E. M., Oosterhuis, J. E., Smeenk, J. M. J., Hoek, A., Broekmans, F. J., Fleischer, K., de Bruin, J. P., Kaaijk, E. M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)33308-1 · Cited by 31
The obesogen tributyltin induces features of polycystic ovary syndrome (PCOS): a review
Merlo, E., Silva, I. V., Cardoso, R. C., & Graceli, J. B. (2018) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2018.1496214 · Cited by 32
Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome
Evliyaoğlu, O., Imöhl, M., Weiskirchen, R., & van Helden, J. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-1059 · Cited by 31
Role of Androgen Receptor for Reconsidering the “True” Polycystic Ovarian Morphology in PCOS
Gao, X., Liu, Y., Lv, Y., Huang, T., Lü, G., Liu, H., & Zhao, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-65890-5 · Cited by 31
Hyperandrogenemia alters mitochondrial structure and function in the oocytes of obese mouse with polycystic ovary syndrome
Chappell, N. R., Zhou, B., Hosseinzadeh, P., Schutt, A. K., Gibbons, W. E., & Blesson, C. S. (2020) · F&S Science · doi:10.1016/j.xfss.2020.12.001 · Cited by 32
Ovarian Reserve Biomarkers and Menstrual Cycle Length in a Prospective Cohort Study
Harris, B. S., Steiner, A. Z., & Jukic, A. M. Z. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab204 · Cited by 32
Unaltered timing of embryo development in women with polycystic ovarian syndrome (PCOS): a time-lapse study
Sundvall, L., Kirkegaard, K., Ingerslev, H. J., & Knudsen, U. B. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0488-0 · Cited by 31
Possible involvement of glucocorticoids in 5α-dihydrotestosterone-induced PCOS-like metabolic disturbances in the rat visceral adipose tissue
Nikolič, M., Μacut, D., Djordjevic, A. D., Veličković, N. A., Nestorović, N. M., Bursać, B. N., Antić, I. B., Macut, J. B., Matić, G. M., & Milutinović, D. V. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.08.013 · Cited by 31
American, European, and Chinese practice guidelines or consensuses of polycystic ovary syndrome: a comparative analysis
Wang, F., Pan, J., Wu, Y. T., Zhu, Y., Hardiman, P. J., & Qu, F. (2018) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1700074 · Cited by 31
Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome
Bagos, P. G. (2008) · Molecular Human Reproduction · doi:10.1093/molehr/gan072 · Cited by 31
Association between maternal polycystic ovarian syndrome undergoing assisted reproductive technology and pregnancy complications and neonatal outcomes: a systematic review and meta-analysis
Ban, M., Sun, Y., Chen, X., Zhou, X., Zhang, Y., & Cui, L. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-023-01331-x · Cited by 30
Leonurine restrains granulosa cell ferroptosis through SLC7A11/GPX4 axis to promote the treatment of polycystic ovary syndrome
Huang, X., Geng, H., Liang, C., Xiong, X., Du, X., Zhuan, Q., Liu, Z., Lin, M., Zhou, D., Zhang, L., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.021 · Cited by 30
Counting ovarian follicles: updated threshold for diagnosis of hyperandrogenic anovulation
Martins, W. P., Kollmann, M., & Raine‐Fenning, N. J. (2014) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.13402 · Cited by 30
Histopathologic and metabolic effect of ursodeoxycholic acid treatment on PCOS rat model
Gözükara, İ., Dokuyucu, R., Özgür, T., Özcan, O., Pınar, N., Kurt, R. K., Kucur, S. K., & Dolapçıoğlu, K. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1134478 · Cited by 30
Association between major dietary patterns and polycystic ovary syndrome: evidence from a case-control study
Shahdadian, F., Ghiasvand, R., Abbasi, B., Feizi, A., Saneei, P., & Shahshahan, Z. (2018) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0145 · Cited by 31
High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients
Guo, Y., Liu, S., Hu, S., Li, F., & Jin, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.673284 · Cited by 30
Quercetin and polycystic ovary syndrome
Ma, C., Xiang, Q., Song, G., & Wang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1006678 · Cited by 36
Role of Artificial Intelligence in PCOS Detection
Agrawal, A., Ambad, R., Lahoti, R., Muley, P. A., & Pande, P. S. (2022) · Journal of Datta Meghe Institute of Medical Sciences University · doi:10.4103/jdmimsu.jdmimsu_278_22 · Cited by 30
Infertility and Risk of Autism Spectrum Disorder in Children
Vélez, M. P., Dayan, N., Shellenberger, J. P., Pudwell, J., Kapoor, D., Vigod, S. N., & Ray, J. G. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.43954 · Cited by 43
Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment
Spritzer, P. M., & Motta, A. B. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12719 · Cited by 30
Potential use of durian fruit (Durio zibenthinus Linn) as an adjunct to treat infertility in polycystic ovarian syndrome
Ansari, R. M. (2016) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(16)60240-6 · Cited by 30
A matter of new life and cell death: programmed cell death in the mammalian ovary
Chesnokov, M. S., Mamedova, A. R., Zhivotovsky, B., & Kopeina, G. S. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01017-6 · Cited by 31
A systematic review and meta-analysis of metformin among patients with polycystic ovary syndrome undergoing assisted reproductive technology procedures
Huang, X., Wang, P., Tal, R., Lv, F., Li, Y., & Zhang, X. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.04.046 · Cited by 32
Uterine Morphology and Peristalsis in Women with Polycystic Ovary Syndrome
Leonhardt, H., Gull, B., Kishimoto, K., Kataoka, M., Nilsson, L., Janson, P. O., Stener-Victorin, E., & Hellström, M. (2012) · Acta Radiologica · doi:10.1258/ar.2012.120384 · Cited by 29
The role of anti-Müllerian hormone in predicting clomiphene citrate resistance in women with polycystic ovarian syndrome
Gülşen, S., Ulu, İ., Köpük, Ş. Y., & Kıran, G. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1499085 · Cited by 29
Profiles for long non-coding RNAs in ovarian granulosa cells from women with PCOS with or without hyperandrogenism
Jin, L., Yang, Q., Zhou, C., Liu, L., Wang, H. H., Hou, M., Wu, Y., Shi, F.-T., Sheng, J., & Huang, H. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.08.005 · Cited by 29
Elevation of antimüllerian hormone in women with polycystic ovary syndrome undergoing assisted reproduction: effect of insulin
Liu, X., Yang, Y. J., Tang, C. L., Wang, K., Chen, J.-J., Teng, X., Ruan, Y. C., & Yang, J. Z. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.09.022 · Cited by 29
Effects of ADIPOQ polymorphisms on PCOS risk: a meta-analysis
Liu, Z., Wang, Z., Hao, C., Tian, Y., & Fu, J. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0439-6 · Cited by 29
Association of circulating monocyte chemoattractant protein‐1 levels with polycystic ovary syndrome: A meta‐analysis
Wu, Z., Fang, L., Li, Y., Yan, Y., Thakur, A., Cheng, J., & Sun, Y. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13407 · Cited by 29
Aberrant H19 Expression Disrupts Ovarian Cyp17 and Testosterone Production and Is Associated with Polycystic Ovary Syndrome in Women
Chen, Z., Liu, L., Xia, X., Burn, M. S., Karakaya, C., & Kallen, A. N. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00700-5 · Cited by 29
Management of reproduction and pregnancy complications in maternal obesity: Which role for dietary polyphenols?
Santangelo, C., Varı́, R., Scazzocchio, B., Filesi, C., & Masella, R. (2013) · BioFactors · doi:10.1002/biof.1126 · Cited by 30
Effects of androgen and leptin on behavioral and cellular responses in female rats
Feng, Y., Shao, R., Weijdegård, B., Wang, T., Johansson, J., Sun, S., Wang, W., Egecioglu, E., Billig, H., & Stener‐Victorin, E. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.07.012 · Cited by 29
Lien physiopathologique entre syndrome des ovaires polymicrokystiques et hyperprolactinémie : mythe ou réalité ?
Robin, G., Catteau-Jonard, S., Young, J., & Dewailly, D. (2011) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2010.11.002 · Cited by 29
Self-citation
Polymorphisms and haplotypes of the TGF-β1 gene are associated with risk of polycystic ovary syndrome in Chinese Han women
Yang, J., Zhong, T., Xiao, G., Chen, Y., Liu, J., Xia, C., Du, H., Kang, X., Lin, Y.-Y., Guan, R., et al. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.11.004 · Cited by 29
Chronic-Intermittent Cold Stress in Rats Induces Selective Ovarian Insulin Resistance1
Dorfman, M. D., Ramirez, V. D., Stener‐Victorin, E., & Lara, H. E. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.108.070904 · Cited by 29
Effect of exposure to second-hand smoke from husbands on biochemical hyperandrogenism, metabolic syndrome and conception rates in women with polycystic ovary syndrome undergoing ovulation induction
Li, J., Wu, Q., Wu, X.-K., Zhou, Z.-M., Fu, P., Chen, X.-H., Yan, Y., Wang, X., Yang, Z.-W., Li, W.-L., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey027 · Cited by 29
Self-citation
Methodological and reporting quality evaluation of systematic reviews on acupuncture in women with polycystic ovarian syndrome: A systematic review
Luo, Y., Zheng, Q., Liu, Z., Zhang, F., Chen, Y., & Li, Y. (2018) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2018.10.002 · Cited by 28
Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway
Yang, D., Wang, Y., Zheng, Y., Dai, F., Liu, S., Yuan, M., Deng, Z., Bao, A., & Cheng, Y. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00792-2 · Cited by 29

Authors: Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E.
Affiliations: The University of Adelaide (AU)
Centre Hospitalier Universitaire de Lille (FR)
Pennsylvania State University (US)
Corresponding author: Hickey, Theresa E
ORCID: Norman, Robert J
Dewailly, Didier
Legro, Richard S
Hickey, Theresa E
Venue: The Lancet
Publisher: Elsevier BV
Published: 2007-08
Volume: 370
Issue: 9588
Pages: 685-697
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(07)61345-2
OpenAlex: W2499178053
Cited by: 1,360
References: 181
Citations by year: 2026: 43 · 2025: 61 · 2024: 100 · 2023: 100 · 2022: 101 · 2021: 105 · 2020: 94 · 2019: 86 · 2018: 86 · 2017: 74 · 2016: 78 · 2015: 70 · 2014: 62 · 2013: 52 · 2012: 60
FWCI: 6.99
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords: polycystic ovary syndrome, hyperandrogenism, insulin resistance, menstrual disorders, infertility, hirsutism, acne, obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, diagnostic criteria, chronic anovulation, polycystic ovary, genetic susceptibility, lifestyle factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Polycystic ovary syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks